Determinants of Greater Peak radiation skin dose in percutaneous coronary intervention for chronic total occlusion

被引:5
|
作者
Yamamoto, Kei [1 ]
Sakakura, Kenichi [1 ]
Hamamoto, Kohei [2 ]
Hasegawa, Hiroko [1 ]
Tsukui, Takunori [1 ]
Seguchi, Masaru [1 ]
Taniguchi, Yousuke [1 ]
Wada, Hiroshi [1 ]
Momomura, Shin-ichi [1 ]
Fujita, Hideo [1 ]
机构
[1] Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Omiya Ku, 1-847 Amanuma Cho, Saitama, Saitama 3308503, Japan
[2] Jichi Med Univ, Saitama Med Ctr, Dept Radiol, Saitama, Japan
关键词
Peak skin dose; Percutaneous coronary intervention; Chronic total occlusion; MULTICENTER CTO REGISTRY; INTRAVASCULAR ULTRASOUND; PREDICTORS; EXPOSURE; OUTCOMES; RECANALIZATION; INSIGHTS; SCORE;
D O I
10.1016/j.jjcc.2020.02.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Peak skin dose (PSD) is closely associated with skin radiation injuries such as skin ulcers in percutaneous coronary intervention (PCI). Although PSD is greater in PCI for chronic total occlusion (CTO) lesions as compared with non-CTO lesions, the determinants of PSD in CTO-PCI are not fully understood. The purpose of this study was to investigate the clinical factors associated with excess PSD in PCI for CTO. Methods: The study population included a total of 220 CTO-PCI cases that were divided into a standard PSD group (<2 Gy, n = 187) and an excess PSD group (>= 2 Gy, n = 33). Clinical, lesion, and procedural characters were compared between the 2 groups. Multivariate logistic regression was performed to investigate the clinical factors associated with excess PSD. Results: Body surface area (BSA) was significantly higher in the excess PSD group (1.85 +/- 0.24 m(2)) than the standard PSD group (1.71 +/- 0.18 m(2)) (p = 0.001). The J-CTO score was significantly higher in the excess PSD group (2.51 +/- 1.28) than the standard PSD group (1.60 +/- 1.13) (p < 0.001). Multivariate logistic regression analysis revealed that BSA (0.1 mm increase: OR 1.663, 95% CI 1.300-2.128, p < 0.001) and J-CTO score (1-point increase: OR 2.015, 95% CI 1.322-3.071, p = 0.001) were significantly associated with excess PSD. Conclusions: A large BSA and high J-CTO score were significantly associated with excess PSD. It is important to pay special attention to CTO patients who have a large BSA and/or high J-CTO score to reduce patient's PSD. (C) 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 50 条
  • [1] Determinants of Greater Peak Radiation Skin Dose in Contemporary Percutaneous Coronary Interventions
    Hasegawa, Hiroko
    Sakakura, Kenichi
    Hamamoto, Kohei
    Yamamoto, Kei
    Taniguchi, Yousuke
    Tsukui, Takunori
    Seguchi, Masaru
    Wada, Hiroshi
    Momomura, Shin-ichi
    Fujita, Hideo
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2020, 21 (01) : 6 - 11
  • [2] Patients' skin dose during percutaneous coronary intervention for chronic total occlusion
    Suzuki, Shigeru
    Furui, Shigeru
    Isshiki, Takaaki
    Kozuma, Ken
    Koyama, Yutaka
    Yamamoto, Hiroyuki
    Ochiai, Masahiko
    Asakura, Yasushi
    Ikari, Yuji
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2008, 71 (02) : 160 - 164
  • [3] CLINICAL DETERMINANTS OF RADIATION SKIN DOSE IN ADULT PERCUTANEOUS CORONARY INTERVENTION
    Fetterly, Kenneth A.
    Lennon, Ryan J.
    Bell, Malcolm R.
    Holmes, David R., Jr.
    Rihal, Charanjit S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [4] Determinants of Choice for Percutaneous Coronary Intervention in Patients with Coronary Artery Chronic Total Occlusion
    Li, Chenguang
    Liu, Xuebo
    Dai, Yuxiang
    Qian, Juying
    Ge, Lei
    Fan, Bing
    Wang, Qibing
    Zhong, Xin
    Ge, Junbo
    CIRCULATION, 2010, 122 (02) : E335 - E335
  • [5] On-line estimated peak skin dose during percutaneous coronary intervention for chronic total occlusion using new patient dose mapping technology
    Lefevre, Thierry
    Mangiameli, Andrea
    Hovasse, Thomas
    Louvard, Yves
    Benamer, Hakim
    Garot, Philippe
    Unterseeh, Thierry
    Champagne, Stephane
    Tavolaro, Oscar
    Amelot, Sophie
    Chevalier, Bernard
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2022, 115 (8-9) : 436 - 447
  • [6] Chronic Total Occlusion Percutaneous Coronary Intervention
    Chung C.J.
    Finn M.T.
    Hatem R.
    Green P.
    Kirtane A.J.
    Karmpaliotis D.
    Current Cardiovascular Risk Reports, 2016, 10 (12)
  • [7] Chronic total coronary occlusion percutaneous intervention
    Reifart, Nicolaus
    EUROINTERVENTION, 2014, 9 (10) : 1139 - 1140
  • [8] Percutaneous Coronary Intervention in Chronic Total Occlusion
    Ybarra, Luiz Fernando
    Cantarelli, Marcelo J. C.
    Lemke, Viviana M. G.
    de Quadros, Alexandre Schaan
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2018, 110 (05) : 476 - 483
  • [9] Factors affecting the patient's skin dose during percutaneous coronary intervention for chronic total occlusion
    Suzuki, Shigeru
    Furui, Shigeru
    Isshiki, Takaaki
    Kozuma, Ken
    Endo, Goro
    Yamamoto, Yoshito
    Yokoyama, Naoyuki
    CIRCULATION JOURNAL, 2007, 71 (02) : 229 - 233
  • [10] Methods to reduce patients' maximum skin dose during percutaneous coronary intervention for chronic total occlusion
    Suzuki, Shigeru
    Furui, Shigeru
    Isshiki, Takaaki
    Kozuma, Ken
    Koyama, Yutaka
    Ochiai, Masahiko
    Asakura, Yasushi
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2008, 71 (06) : 792 - 798